Blue Water Vaccines Presents New Data Supporting Universal Influenza Vaccine Candidate at the World Vaccine Congress 2022 in Washington, DC
CINCINNATI, April 21, 2022 (GLOBE NEWSWIRE) — Blue Water Vaccines Inc. (“BWV” or “Blue Water…
Year: 2022
Homology Medicines Announces Promotion of Albert Seymour, Ph.D., to President
BEDFORD, Mass., April 21, 2022 (GLOBE NEWSWIRE) — Homology Medicines, Inc. (Nasdaq: FIXX), a genetic…
G1 Therapeutics to Release First Quarter 2022 Financial Results and Provide Business Update on May 4, 2022
RESEARCH TRIANGLE PARK, N.C., April 21, 2022 (GLOBE NEWSWIRE) — G1 Therapeutics, Inc. (Nasdaq: GTHX),…
Mustang Bio Announces Upcoming MB-106 CD20-Targeted CAR T Data Presentations
Fred Hutch’s Dr. Mazyar Shadman to present data on Mustang’s autologous CAR T-cell therapy for…
AIM ImmunoTech Provides Summary of Ampligen® Data Supporting Synergistic Potential with Checkpoint Blockade Therapies
Robert Edwards, MD Robert Edwards, MD Michael (Tony) Hollingsworth, PhD Michael (Tony) Hollingsworth, PhD Pawel…
Spero Therapeutics to Present Data at the 32nd European Congress of Clinical Microbiology and Infectious Diseases
CAMBRIDGE, Mass., April 21, 2022 (GLOBE NEWSWIRE) — Spero Therapeutics, Inc. (Nasdaq: SPRO) today announced two…
BetterLife To Present BETR-001 Preclinical Data at the Upcoming Canadian Association for Neuroscience Conference
VANCOUVER, British Columbia, April 21, 2022 (GLOBE NEWSWIRE) — BetterLife Pharma Inc. (“BetterLife” or the…
Enzyvant Announces Plans to Expand Regenerative Medicine Manufacturing Capabilities
State-of-the-art facility will expand capacity for producing tissue-based and additional regenerative medicines CAMBRIDGE, Mass. and…
Innovative Cellular Therapeutics (ICT) Announces Data Presentation at the American Association for Cancer Research (AACR) Annual Meeting
Clinical Data from one research site for GCC19CART, ICT’s lead solid tumor program, for 3rd…
Achieve Life Sciences to Announce First Quarter Financial Results and Host Conference Call and Webcast on May 12, 2022
SEATTLE and VANCOUVER, British Columbia, April 21, 2022 (GLOBE NEWSWIRE) — Achieve Life Sciences, Inc….
Cocrystal Pharma Collaborates with the National Institute of Allergy and Infectious Diseases to Evaluate COVID-19 Protease Inhibitors
BOTHELL, Wash., April 21, 2022 (GLOBE NEWSWIRE) — Cocrystal Pharma, Inc. (Nasdaq: COCP) (“Cocrystal” or…
Motus GI Completes Enrollment in the European Union Feasibility Study of the Pure-Vu® System as a New Method for Bowel Cleansing in Patients with a History of Poor Bowel Preparation
Topline data expected to be presented at a scientific conference in May 2022 Independent data…
Impel NeuroPharma to Ring Nasdaq Closing Bell on Monday, April 25
Impel Celebrates Its One-Year Anniversary as a Public Company SEATTLE, April 21, 2022 (GLOBE NEWSWIRE)…
Accelus Announces First Procedure Integrating Remi Robotic Navigation System, LineSider Spinal System, and FlareHawk Expandable Interbody Fusion Device Technologies
Tien V. Le, M.D., recently performed the first procedure integrating the Remi Robotic Navigation System,…
Aileron Expands Management Team with Appointment of Christopher Zergebel As Vice President, Program Management and Clinical Operations
Mr. Zergebel brings over 20 years of industry experience, primarily focused in oncology, and broad…
Codexis and seqWell Announce Strategic Investment and Partnership Initiation
seqWell raises $7M Series C funding, led by Codexis Current investors Research Corporation Technologies and…
Todos Medical Appoints Philippe Goix as Chief Commercial Officer for Provista Diagnostics
Strengthens Management Team and Positions the Company for Growth and Expansion New York, NY, and…
Arbutus to Report First Quarter 2022 Financial Results and Provide Corporate Update
WARMINSTER, Pa., April 21, 2022 (GLOBE NEWSWIRE) — Arbutus Biopharma Corporation (Nasdaq: ABUS), a clinical-stage…
InMed Commercializes Cannabidivarin (CBDV), Expanding its Rare Cannabinoid Portfolio for the Health and Wellness Sector
Expands rare cannabinoid portfolio beyond current CBC and CBT Releases White Paper outlining research into…
Chalice Brands Ltd. Announces Execution of Definitive Agreements to Acquire Oregon Retail Stores and Cultivation Assets
PORTLAND, Ore., April 21, 2022 (GLOBE NEWSWIRE) — Chalice Brands Ltd. (CSE: CHAL) (OTCQB: CHALF)…